Advertisement
BNGO vs RGEN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a Hold and RGEN is a Buy.
BNGO | RGEN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 95 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 88 | |
PRICE GROWTH RATING 1..100 | 36 | 37 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BNGO's Valuation (23) in the Biotechnology industry is somewhat better than the same rating for RGEN (86). This means that BNGO’s stock grew somewhat faster than RGEN’s over the last 12 months.
BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGEN (100). This means that BNGO’s stock grew similarly to RGEN’s over the last 12 months.
RGEN's SMR Rating (88) in the Biotechnology industry is in the same range as BNGO (98). This means that RGEN’s stock grew similarly to BNGO’s over the last 12 months.
BNGO's Price Growth Rating (36) in the Biotechnology industry is in the same range as RGEN (37). This means that BNGO’s stock grew similarly to RGEN’s over the last 12 months.
BNGO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RGEN (100). This means that BNGO’s stock grew similarly to RGEN’s over the last 12 months.
| BNGO | RGEN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 72% |
| Momentum ODDS (%) | 1 day ago 77% | 1 day ago 75% |
| MACD ODDS (%) | 1 day ago 78% | 1 day ago 78% |
| TrendWeek ODDS (%) | 1 day ago 89% | 1 day ago 72% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 72% |
| Advances ODDS (%) | 12 days ago 76% | 5 days ago 73% |
| Declines ODDS (%) | 1 day ago 89% | 17 days ago 81% |
| BollingerBands ODDS (%) | 1 day ago 87% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 61% | 1 day ago 82% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BNGO’s FA Score shows that 1 FA rating(s) are green while RGEN’s FA Score has 0 green FA rating(s).
- BNGO’s FA Score: 1 green, 4 red.
- RGEN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BNGO’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 3 bullish TA indicator(s).
- BNGO’s TA Score: 4 bullish, 4 bearish.
- RGEN’s TA Score: 3 bullish, 5 bearish.
Price Growth
BNGO (@Pharmaceuticals: Other) experienced а -4.05% price change this week, while RGEN (@Pharmaceuticals: Other) price change was +7.23% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.16%. For the same industry, the average monthly price growth was -3.39%, and the average quarterly price growth was +19.68%.
Reported Earning Dates
BNGO is expected to report earnings on Oct 29, 2026.
RGEN is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+1.16% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
BNGO and
Correlation & Price change
A.I.dvisor tells us that BNGO and RGEN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNGO and RGEN's prices will move in lockstep.
| Ticker / NAME | Correlation To BNGO | 1D Price Change % | ||
|---|---|---|---|---|
| BNGO | 100% | -1.78% | ||
| RGEN - BNGO | 30% Poorly correlated | -0.51% | ||
| ARAY - BNGO | 30% Poorly correlated | -3.54% | ||
| PACB - BNGO | 29% Poorly correlated | +2.53% | ||
| VIVO - BNGO | 29% Poorly correlated | +1.35% | ||
| DRIO - BNGO | 28% Poorly correlated | -2.07% | ||
More | ||||
RGEN and
Correlation & Price change
A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.
| Ticker / NAME | Correlation To RGEN | 1D Price Change % | ||
|---|---|---|---|---|
| RGEN | 100% | -0.51% | ||
| DHR - RGEN | 67% Closely correlated | +0.32% | ||
| A - RGEN | 65% Loosely correlated | -0.03% | ||
| BIO - RGEN | 60% Loosely correlated | -1.69% | ||
| MTD - RGEN | 59% Loosely correlated | -0.49% | ||
| TMO - RGEN | 58% Loosely correlated | -0.50% | ||
More | ||||